Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Bupivacaine × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3 Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Pain, Postoperative 4 Colorectal Neoplasms 4 Rectal Neoplasms 3 Colonic Neoplasms 2 Agnosia 2 Stomach Neoplasms 1 Pain 1 Neuralgia 1 Neoplasms 1 Liver Neoplasms 1 Intestinal Perforation 1 Intestinal Diseases 1 Inflammatory Bowel Diseases 1 Ileus 1 Gastrointestinal Neoplasms 1 Gastrointestinal Diseases 1 Duodenal Neoplasms 1 Diverticulosis, Colonic 1 Diverticulitis, Colonic 1 Digestive System Diseases 1 Crohn Disease 1 Constipation 1

Interventions

Gemcitabine 61 Fluorouracil 40 pembrolizumab 39 Oxaliplatin 39 Capecitabine 38 Bevacizumab 35 Leucovorin 33 Irinotecan 29 Cisplatin 25 Nivolumab 22 Paclitaxel 20 130-nm albumin-bound paclitaxel 19 Sorafenib 18 Cetuximab 17 Panitumumab 16 Albumin-Bound Paclitaxel 16 Cyclophosphamide 15 Radiotherapy 14 Docetaxel 13 Drug Therapy 12 Blood Specimen Collection 12 Exercise 10 budigalimab 9 atezolizumab 9 Taxes 9 IFL protocol 8 Folfox protocol 8 Carboplatin 8 trametinib 7 lenvatinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02210260 2016-09-14

PROSP

York Teaching Hospitals NHS Foundation Trust

Phase NA Completed

Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡